Secondary enhancers synergise with primary enhancers to guarantee fine-tuned muscle gene expression  by Guerrero, Lucia et al.
Developmental Biology 337 (2010) 16–28
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logySecondary enhancers synergise with primary enhancers to guarantee ﬁne-tuned
muscle gene expression
Lucia Guerrero a,1, Raquel Marco-Ferreres a,1,2, Antonio L. Serrano b,
Juan J. Arredondo a,⁎, Margarita Cervera a,⁎
a Departamento de Bioquímica & Instituto Investigaciones Biomédicas, Facultad de Medicina, UAM-CSIC, Spain
b Departament de Ciencies Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED),
Dr. Aiguader 88, E-08003 Barcelona, Spain⁎ Corresponding authors. Departamento de Bioquím
Arzobispo Morcillo 4, 28029 Madrid, Spain. Fax: +34 9
E-mail addresses: jjarredondo@iib.uam.es (J.J. Arred
margarita.cervera@uam.es (M. Cervera).
1 These authors contributed equally to this work and
2 Present address: Instituto Cajal-CSIC, 37 Av. Dr Arce
0012-1606/$ – see front matter © 2009 Elsevier Inc. A
doi:10.1016/j.ydbio.2009.10.006a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 17 April 2009
Revised 15 September 2009
Accepted 3 October 2009






Mouse fast, slow and cardiac Troponin I genesAlthough tight quantitative control of gene expression is required to ensure that organs and tissues function
correctly, the transcriptional mechanisms underlying this process still remain poorly understood. Here, we
describe novel and evolutionary conserved secondary enhancers that are needed for the regulation of the
expression of Troponin I genes. Secondary enhancers are silent when tested individually in electroporated
muscles but interact with the primary enhancers and are required to precisely control the appropriate
timing, the tissue and ﬁbre speciﬁcity, and the quantitative expression of these genes during muscle
differentiation. Synergism is completely dependent of the fully conserved MEF2 site present on the primary
enhancers core of skeletal muscle Troponin I genes. Thus, while each of these paired enhancers has a
different function, the concerted action of both is crucial to recapitulate endogenous gene expression.
Through comparative genomics, we predict that this mechanism has also arisen in other mammalian muscle
genes. Our results reveal the existence of a novel mechanism, conserved from ﬂies to mammals, to ﬁne-tune
gene expression in each muscle and probably other tissues.
© 2009 Elsevier Inc. All rights reserved.Introduction
Enhancers are the most prevalent class of cis-regulatory DNA
elements that determine when and where a given gene is expressed
during development and, in recent years, many cis-acting elements that
regulate spatio-temporal gene expression have been described (Arbeit-
man et al., 2002; Arnone et al., 2004; Brown et al., 2007; Carvajal et al.,
2008;Honget al., 2008; Philippakis et al., 2006). Enhancers interactwith
basal promoters to precisely modulate the rates of transcription, the
quantitative levels of gene expression, and to confer spatial and
temporal speciﬁcity. Hence, they guarantee the correct functioning of
tissues and organs by ensuring that thresholds of a speciﬁc regulator are
reached appropriately, and that the correct stoichiometry is established
for the assembly of multi-protein complexes. Thus, a better under-
standing of the complex mechanisms underlying their activity is crucial
to be able to deﬁne how gene expression is controlled.
Muscle differentiation is an exceptional model system to
investigate the precise developmental regulation of tissue-speciﬁcica, Facultad Medicina, UAM,
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ll rights reserved.genes. In Drosophila, two separate enhancers control highly dynamic
and exquisitely coordinated patterns of sarcomeric gene expression
(Garcia-Zaragoza et al., 2008; Marco-Ferreres et al., 2005; Mas et al.,
2004). When tested in transgenic animals, each enhancer of the pair
is transcriptionally active and it can independently drive similar
expression patterns to the paired enhancers in all muscle-types.
Interestingly, although each enhancer can determine muscle speci-
ﬁcation, it cannot recapitulate the levels of expression of the
endogenous gene in each muscle subtype. Thus, the concerted action
of both enhancers in a differentiated and synergistic manner is
required to control global regulation in vivo (Garcia-Zaragoza et al.,
2008; Marco-Ferreres et al., 2005; Marin et al., 2004; Mas et al.,
2004). Generally, one of the enhancers of the pair is situated at the 5′
ﬂanking region of the gene while the other is associated with the ﬁrst
intron. In general, enhancers are occupied by macromolecular
complexes that interact among themselves, as well as with proximal
promoters to trigger transcription. Enhancer occupancy and the
composition of the binding complexes may vary depending on the
muscle subtype and the developmental stage in order to ensure the
appropriate spatio-temporal expression of the gene in question. On
the basis of our previous studies, we suggested that paired functional
enhancers might arise from duplication to guarantee ﬁbre speciﬁcity
and the ﬁne-tuning of gene expression levels in each particular
muscle (Garcia-Zaragoza et al., 2008; Marco-Ferreres et al., 2005;
Mas et al., 2004).
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Drosophila genes, such as some neurogenic target genes of the Dorsal
transcription factor, a protein related to the mammalian NF-κB, that
controls the dorsal–ventral patterning of the early embryo (Hong et
al., 2008). These genes contain two enhancers referred to as primary
and secondary enhancers. The primary enhancer usually lies in the 5′
ﬂanking region of the gene, while the secondary enhancer in some
cases maps within 5 kb of the transcription initiation site, although in
some other cases it may lie tens of kilobases away. Indeed, it was
suggested that these remote secondary enhancers, which mediate
activities overlapping the primary enhancer and that ensure precise
and reproducible patterns of gene expression during embryogenesis,
be known as “shadow enhancers” (Hong et al., 2008).
Within this scenario, it is relevant to determine whether the
mechanisms used by Drosophila to ﬁne-tune the expression of muscle
and neurogenic genes are evolutionary conserved (Cervera et al.,
2006; Hong et al., 2008;Marco-Ferreres et al., 2005;Marin et al., 2004;
Mas et al., 2004). In other words, how do mammalian genes ﬁne-tune
spatio-temporal gene expression? The Troponin I gene family
contains three related genes that encode slow (sTnI; TNNI1) and
fast (fTnI; TNNI2) skeletal muscle, and cardiac (cTnI; TNNI3) muscle
isoforms. These three genes have been widely used as model system
to study muscle-speciﬁc gene transcription in mammals (Cullen et al.,
2004; Dhoot and Perry, 1979; Hastings, 1997). The presence of a cis-
regulatory element in each gene has been shown to be relevant in
order to obtain ﬁbre-type speciﬁc expression in transgenicmice. Thus,
a 128 bp troponin I Slow Upstream Regulatory Element (SURE) and a
144 bp troponin I Fast Intronic Regulatory Element (FIRE) have been
described that restrict sTnI and fTnI expression to slow and fast ﬁbres,
respectively, thereby conferring ﬁbre-type speciﬁcity (Calvo et al.,
1999; Calvo et al., 2001; Hallauer and Hastings, 2002; Levitt et al.,
1995; Nakayama et al., 1996; Rana et al., 2008; Yutzey et al., 1989). In
addition, it has been demonstrated that a 356 bp upstream regulatory
element within cardiac Troponin I controls heart muscle speciﬁcity
(Di Lisi et al., 1998; Di Lisi et al., 2007). However, FIRE-driven trans-
gene expression does not exactly correlate with the endogenous fTnI
gene (Hallauer et al., 1993; Hallauer and Hastings, 2002).
To investigate the mechanisms that mediate the precise develop-
mental regulation of tissue-speciﬁc genes in mammals, we have
focused our studies on the TnI gene family. Here, we describe the
identiﬁcation of new evolutionary conserved enhancers that act as
secondary enhancers in all three mammalian TnI genes.
Materials and methods
Sequence analysis and comparative genomics
The evolutionary conserved regions in the genomic sequences
containing the sTnI, fTnI and cTnI genes of several mammal species
(mouse, rat, dog and human) were analysed using the ECR Browser
(ecrbrowser.dcode.org: Ovcharenko et al., 2004). Conserved potential
binding sites for transcription factors were analysed with the Mulan
(mulan.dcode.org) and MultiTF (multitf.dcode.org) servers.
Reporter constructions
The SURE (−2508/+56), SIRE (+36/+3021), SIRE2 (+2999/
+5468), SURE–SIRE (−2508/+3021) fragments from the sTnI gene,
the FURE (−1243/+37), FIRE (+17/+672), FIRE2 (+651/+1359),
FURE–FIRE (−1243/+672), FURE–FIRE–FIRE2 (−1243/+1359),
FURE–FIRE2 (−1243/+37 and +651/+1359), FURE promoterless
(pl) (−1243/−86), FURE–FIRE pl (−1243/+672 Δ−86/+17), core
FIRE (+251/+522), FURE–core FIRE (−1243/−86 and+251/+522)
fragments from the fTnI gene and the CURE (−230/+126), CIRE
(+127/+1363), CURE–CIRE (−230/+1363) fragments from the cTnI
gene were ampliﬁed by PCR with speciﬁcally designed primers(primer sequences are available upon request). FIRE-ΔMEF and FURE–
FIRE-ΔMEF are exactly the same than FIRE and FURE–FIRE pl,
respectively, in which the MEF2 binding site has been deleted by
PCR following standard protocols. All fragments were cloned into a
pBluescript-derived vector upstream of the β-globin minimal pro-
moter and the LacZ gene (the plasmidwas a gift fromM.Manzanares).
Cell culture and transfections
C2C12 mouse myoblasts were maintained in DMEM (Gibco)
supplemented with L-glutamine, gentamycin and 10% foetal bovine
serum (FBS). Differentiation of conﬂuent monolayers of myoblasts
was induced by replacing FBS with 2% horse serum (differentiation
medium). Cultured cells were maintained at 37 °C in 5% CO2.
For transient transfection assays, 1.75×105 cells were plated in
35 mm culture dishes and after 24 h, proliferating myoblasts were
transfected using Lipofectamine (Invitrogen) with 1.5 μg of each LacZ
construct. Differentiation was induced 24 h after transfection and β-
galactosidase activity was analysed after 0 and 5 days of differentia-
tion. All transfection experiments were repeated at least ﬁve times
unless otherwise indicated.
To normalise for transfection efﬁciency, the cells were co-
transfected with 0.1 μg of either pEGFP when the cells were to be
analysed in Western blots, or pCMVluc when the cells were used to
measure β-galactosidase activity. Expression of EGFP and Luciferase is
driven by a CMV promoter.
Primary cardiomyocyte culture and transfection
One day old rat cardiomyocytes were isolated and cultured using a
commercially available neonatal rat/mouse cardiomyocyte isolation
kit (Cellutron Life Technologies) according to the manufacturer's
instructions. For transient transfection, 7×105 cells were plated in
35 mm culture precoated dishes and the cells were maintained in
serum free medium at 37 °C in 5% CO2. Cardiomyocyte cultures
were transfected 48 h after plating using Lipofectamine (Invitrogen)
with 1.5 μg of each LacZ construct and 0.1 μg of pCMVluc as a cont-
rol for transfection efﬁciency. Differentiation was induced 24 h
after transfection and β-galactosidase activity was analysed after 0
and 3 days of differentiation. Transfection experiments were repeated
4 times and each experiment contained triplicates for each construct.
X-Gal staining
Cells were rinsed in cold PBS and then ﬁxed for 10 min in 2%
formaldehyde and 0.2% glutaraldehyde in PBS. The cells were then
washed twice for 10 min in PBS and stained for 4 h at 37 °C in a PBS
solution containing 5 mM potassium ferrocyanide, 5 mM potassium
ferricyanide, 2 mM MgCl2 and X-Gal 1 mg/ml. The cells were washed
in PBS and then observed under a light microscope. The same staining
procedure was used for muscle sections on slides to detect ﬁbres
expressing LacZ. Incubation times varied from 2 to 24 h to visualise
the LacZ expressing ﬁbres and the staining intensity was monitored
under the microscope at regular time intervals.
Quantiﬁcation of β-galactosidase activity
Cells were lysed in Glo Lysis Buffer (Promega) and β-galactosidase
activity was determined with the Beta-Glo Assay System (Promega).
Brieﬂy, 40 μl of each cell extract was mixed with 40 μl of the Beta-Glo
reagent and incubated for 30 min. Luminescence was then measured
in an Optocom I luminometer and the β-galactosidase units were
normalised to the luciferase activity of the pCMVLuc control plasmid.
Luciferase activity was determined in the same extracts with the
Luciferase Assay System (Promega), following the manufacturer's
instructions. Relative β-galactosidase activity is given as the β-gal/Luc
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each sample measured with the Bio-Rad Protein Assay (Bio-Rad) or
Micro BCA Protein Assay (Pierce).
Western blotting
Rat muscles were homogenised in lysis buffer (1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS and protease inhibitors in PBS) and
cleared at 10,000 rpm for 10 min at 4 °C. Each protein extract (20 μg)
was loaded onto 10% SDS-polyacrylamide gels, and transferred to
PVDF membranes (Inmobilon, Millipore). Western blotting was
carried out as described previously (Marco-Ferreres et al., 2005)
and the membranes were probed with antibodies against TnI (H-170,
Sta. Cruz Biotech.) and GFP (molecular probes) diluted 1:1000, or with
an antibody against Luciferase (251-550, Sta. Cruz Biotech.) or β-
galactosidase (Cappel) at 1: 2000.
Muscle transfection by in vivo electroporation
The speciﬁcity of the different plasmid constructs for slow and fast
muscles was studied in adult 200–250 g male Wistar rats. Soleus and
extensor digitorum longus (EDL) muscles were transfected by
intramuscular injection of plasmid DNA (25 μg), followed by
electroporation to increase gene transfer efﬁciency as published
previously (Serrano et al., 2001). Co-transfection of 2.5 μg of a GFP-
expressing plasmid was used to identify the transfected ﬁbres. The
muscles were removed 7 days after electroporation, frozen in
isopentane, cooled in liquid nitrogen and stored at −80 °C before
they were analysed.
Histological procedures and data analysis
Serial cryostat cross-sections (10 μm thickness) from control and
transfected muscles were obtained and examined by standard
immunohistochemical procedures for the expression of LacZ (see
above), GFP and myosin heavy chain (MHC) isoforms (Serrano et al.,
2001). The primary monoclonal antibodies employed were A4.840
speciﬁc to rat slow MHC (Developmental Studies Hybridoma Bank);
A4.74, which stains rat 2A strongly and 2X/2D MHC weakly
(Developmental Studies Hybridoma Bank); and BF-F3 speciﬁc for
rat 2B MHC (Schiafﬁno et al., 1989). Micrographs were obtained on a
Leica DMR microscope equipped with a camera and serial digitalised
images were taken from the same GFP positive areas on different
cryosections to study the correspondence between the LacZ and
MHC expression in individual muscle ﬁbres. Five muscles of each
type were analysed for each LacZ expressing plasmid construct
transfected.
Results
Evolutionary conserved sequences and modules in the slow and fast
TnI genes
Conserved non-coding regions are likely to deﬁne elements that
are important for the regulation of gene transcription. Indeed,
comparative genomic tools have helped to identify a signiﬁcant
number of functional regulatory sequences based on evolutionary
constraints (Cheng et al., 2007; Konig et al., 2002; Li et al., 2007). To
determine whether mammalian TnI genes follow the same mechan-
istic logic as Drosophilamuscle genes, involving conserved regulatory
modules that interact synergistically to ﬁne-tune gene expression, we
performed a detailed in silico and functional analysis of new
regulatory elements in the two mouse skeletal Troponin I genes:
sTnI and fTnI genes. We examined the sequences of the sTnI and fTnI
loci using the ECR Browser bioinformatics tool (Ovcharenko et al.,
2004), comparing both loci from the human genome with those frommouse, rat and dog. With a conservation cut-off of 70% identity over
100 base pairs, values that are reasonable to determine only
signiﬁcant alignments, several highly conserved non-coding regions
were identiﬁed in both genes, which lay upstream of the transcription
start site and in the ﬁrst introns (Fig. 1 and Supplementary Figs. S1 and
S2). In the mouse sTnI gene, our bioinformatics analysis revealed four
highly conserved modules in the 5′ upstream region (at positions
−2462/−2252, −2101/−1892, −907/−725 and −115/+97) and
two modules in introns 1 and 2 (at positions +1006/+1689 and
+3704/+3916, Fig. 1A and Supplementary Fig. S1). The upstream
−907/−725 sequence includes the SURE primary enhancer pre-
viously described in rat (Banerjee-Basu and Buonanno, 1993; Calvo
et al., 1996; Nakayama et al., 1996) and the −115/+97 fragment
contains the basal promoter and exon 1. In the mouse fTnI gene, three
conserved modules were identiﬁed in the upstream region (at
positions −1153/−972, −904/−682 and −262/+125), as well as
two conserved fragments in introns 1 and 2 (at positions+251/+522
and +952/+1212, Fig. 1B and Supplementary Fig. S2). The +251/
+522 sequence located in intron 1 includes the primary enhancer
FIRE reported to be involved in muscle speciﬁcity in the quail
(Hallauer et al., 1993; Hallauer and Hastings, 2002; Yutzey et al.,
1989).
Each one of the primary enhancers, SURE and FIRE, contain in their
sequences a fully conserved MEF2 binding site. Secondary enhancers
do not contain such conserved sites (see Supplementary Figs. S1
and S2).
Thus, as previously reported for the Drosophila muscle genes,
sequence comparison revealed a modular organisation, whereby
regulatory sequences lie in the putative 5′ ﬂanking and in the intronic
regions of both mouse skeletal TnI genes (Marco-Ferreres et al., 2005;
Mas et al., 2004).
Primary and secondary enhancers from mouse slow and fast Troponin I
genes act synergistically to activate reporter gene expression in
C2C12 myotubes
To test whether the conserved upstream and intronic regions
identiﬁed play a role in quantitative transcriptional regulation of TnI
genes, we performed classical transcription assays. In order to avoid
the loss of functional interactions, we analysed the conserved 5′
ﬂanking and intronic regions in the mouse sTnI and fTnI genes,
preserving all the conserved elements as in our previous studies in
Drosophila (see Fig. 2, Materials and methods and Mas et al., 2004).
Although the size of the fragments differed from those reported in
previous studies, we have used the same terminology to avoid
confusion (Banerjee-Basu and Buonanno, 1993; Hallauer and Hast-
ings, 2002; Nakayama et al., 1996). Therefore, the primary enhancers
will be referred to as SURE for sTnI and FIRE for fTnI, and the potential
new secondary enhancers will be named SIRE and SIRE2 for sTnI and
FURE and FIRE2 for fTnI (Fig. 2). To test the predicted regulatory
activity and functional interactions between these primary and
secondary enhancers, we analysed the transcriptional activity of the
different regulatory elements on their own and in the SURE–SIRE and
FURE–FIRE combinations.
Transient transfection assays were performed in which these
constructs were used to drive the expression of a LacZ reporter gene
in C2C12 myoblasts (Fig. 2). C2C12 cells are capable of differentiat-
ing into myotubes in vitro upon withdrawal of growth factors (Yaffe
and Saxel, 1977). In these assays, reporter gene expression was
analysed in myoblasts and myotubes through X-Gal staining, as well
as by measuring β-galactosidase activity and its accumulation in
Western blots (Figs. 3 and 4). When each fragment of the sTnI gene
was transfected on its own, only SURE was able to drive LacZ
expression in differentiated myotubes (Fig. 3). Nevertheless, while a
few SIRE transfected cells displayed X-Gal staining (Fig. 3A), no β-
galactosidase protein could be detected by Western blotting and
Fig. 1. Evolutionary conserved regions in the sTnI (A) and fTnI (B) genes. ECR Browser output. The x-axis of graphs represents the positions in the human genome and the y-axis the
percentage identity between the human and the aligned genome. Redpeaks represent evolutionary conserved regions (ECR) located in intergenic regions, thepinkpeaks represent ECRs in
intronic regions, theyellowpeaks representECRs in thenon-translated regions and thebluepeaks representECRs in thecodingexons. Theparameters used for comparisonwere fragments
N100 bp in length and with N70% identity. In the lower part of each panel, the gene organisation schemes are presented using the same colour code as in the upper panels.
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cells (Figs. 3B and C). As expected, none of the tested fragments
could drive LacZ expression in myoblasts (Fig. 3B). Interestingly, theSURE–SIRE fragment drove very high β-galactosidase expression in
differentiated myotubes. Thus, the upstream region appears to
interact synergistically with the SIRE fragment to increase reporter
Fig. 2. Reporter gene constructs of mouse TnI skeletal muscle genes. The fragments of the mouse sTnI (A) and fTnI gene (B) analysed were cloned into a vector derived from
pBluescript, upstream of the β-globin minimal promoter and the LacZ gene. Grey boxes indicate non-coding ECRs, while white and black boxes represent the non-coding and coding
exons respectively. The core (red box) of both primary enhancers (red lines) is indicated. Black ovals represent MEF2 binding sites.
Fig. 3. SURE and SIRE act synergistically to produce high levels of reporter gene expression in C2C12 myotubes. (A) Detection of LacZ expression by X-Gal staining of C2C12 cells
transfected with SURE, SIRE and SURE–SIRE constructs. Cells were incubated with X-Gal for at least 4 h. DM, differentiation medium. (B) Determination of β-galactosidase levels in
Western blots of extracts from transfected C2C12 myotubes. The levels of GFP and Troponin I used to normalise for transfection efﬁciency and total protein loading are shown. ND,
undifferentiated cells; EV, empty vector. (C) Analysis of β-galactosidase activity in transfected C2C12 myotubes. β-galatosidase activity was normalised to the luciferase activity and
to the protein concentration (see Materials and methods). The results are the means±SE from 7 different experiments (p-value between SURE and SURE¬SIREb0.0001).
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Fig. 4. FURE and FIRE co-operate to produce high levels of reporter gene expression in C2C12 myotubes. (A) Detection of LacZ expression by X-Gal staining of C2C12 cells transfected
with the FIRE, FIRE2, FURE, FURE promoterless (pl), FURE–FIRE2, FURE–FIRE, FURE–FIRE pl and FURE–FIRE–FIRE2 constructs. Cells were incubated with X-Gal for at least 4 h. (B)
Determination of β-galactosidase levels in Western blots of extracts from transfected C2C12 myotubes. The levels of Luciferase and Troponin I used to normalise for transfection
efﬁciency and total protein loading are shown. A gradient from 4% to 12% SDS-PAGE was used. (C) Analysis of β-galactosidase activity in transfected C2C12 myotubes. The β-
galactosidase activity was normalised to the luciferase activity and to the protein concentration (see Materials and methods). The results are the means±SE from 5 different
experiments.
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22 L. Guerrero et al. / Developmental Biology 337 (2010) 16–28gene expression by approximately 3-fold (Fig. 3C). Hence, while the
SIRE fragment is unable to drive LacZ gene expression itself, it
contains elements that co-operate with SURE to regulate the levels
of transcription.
By contrast, when the fTnI gene was analysed the LacZ activity
was exclusively observed in myotubes when the FIRE construct,Fig. 5.MEF2 binding site on the FIRE enhancer is essential for the synergism. (A) Detection o
FIRE, FURE–FIRE, FURE–core FIRE, FIRE-ΔMEF, and FURE–FIRE-ΔMEF constructs. These const
4 h. (B) Determination of β-galactosidase levels in Western blots of extracts from transfe
transfection efﬁciency and total protein loading are shown. (C) Analysis of β-galactosidase
the luciferase activity and to the protein concentration (see Materials and methods). The recontaining the previously described primary enhancer, drove
reporter gene expression (Fig. 4). As for sTnI, none of the other
fragments tested were able to drive LacZ expression in myotubes,
e.g. FURE and FIRE2. Hence, FURE and FIRE co-operated synergis-
tically to drive very strong fTnI gene expression, as did SURE and
SIRE in the sTnI gene (almost 3 times higher: Figs. 4B and C).f LacZ expression by X-Gal staining of C2C12 cells transfected with the FURE, FIRE, core
ructs lack the endogenous promoter of fTnI. Cells were incubated with X-Gal for at least
cted C2C12 myotubes. The levels of Luciferase and Troponin I used to normalise for
activity in transfected C2C12 myotubes. The β-galactosidase activity was normalised to
sults are the means±SE from 4 different experiments.
Fig. 6. Both SURE–SIRE and FURE–FIRE confer ﬁbre-type speciﬁcity in rat Soleus
muscles in vivo. Adult rat Soleus muscles were co-transfected with constructs
harbouring either, SURE–SIRE or FURE–FIRE, and a GFP expression plasmid to normalise
for transfection efﬁciency. Serial transverse cryosections of transfected muscles were
analysed for GFP and LacZ expression and processed for immunohistochemistry with
monoclonal antibodies speciﬁc to slow, 2A and 2B MHC isoforms (Schiafﬁno et al.,
1989). SURE–SIRE transfected type 1 ﬁbres were intensely stained for LacZ while no fast
ﬁbres were stained. Except for an individual ﬁbre, FURE–FIRE transfected type 1 ﬁbres
were not LacZ stained. Since this ﬁbre was positive for MHC-1 and MHC-2A antibodies,
we speculate a possible transition between slow and fast ﬁbres or the presence ofmixed
ﬁbres. Note that all ﬁbres in Soleus are positive for slowmyosin and importantly, LacZ is
only expressed by a few transfected nuclei in an individual ﬁbre. Therefore, LacZ
staining develops in a gradient along the ﬁbre. The different intensities observed
between individual ﬁbres are due to the position of the sections with respect to the
gradient of staining. Black circles identify the same myoﬁbre in the different pictures.
Scale bar, 50 μm.
23L. Guerrero et al. / Developmental Biology 337 (2010) 16–28Since some of the fragments analysed contained the endogenous
promoter, we decided to investigate any possible interference
between the endogenous and the β-globin promoters present in
the plasmids. We examined a set of FURE and FURE–FIRE constructs
in which the endogenous promoter was deleted, and no difference
was observed in the levels of reporter gene expression with respect
to the constructs containing the endogenous promoter (Fig. 4).
Similar results were obtained for the slow TnI gene when the same
experiments were carried out (data not shown). To examine
whether the size of the fragments analysed inﬂuenced transcrip-
tional activity, we also generated two new constructs in which we
added the FIRE2 fragment, of a similar size to FIRE (Fig. 2), to FURE
and FURE–FIRE constructs. FURE–FIRE2 construct showed similar
levels of LacZ expression to that of FURE alone, even though its size
was similar to that of FURE–FIRE. To complete our analysis and to
further address whether the length of the enhancer inﬂuenced the
level of reporter gene expression, we generated the construct FURE–
FIRE–FIRE2. Signiﬁcantly, the reporter gene expression driven by
this construct was equivalent to that observed with FURE–FIRE
(Fig. 4).
The synergism is fully dependent on the conserved MEF2 binding site
present on the primary enhancers
We have demonstrated a clear co-operativity and synergism
between two separate regulatory elements (upstream and intronic
enhancer elements) in mouse C2C12 cells (Figs. 3 and 4). In this
context, the function of the conserved region in FIRE, which has
already been shown to be a true enhancer, namely core FIRE
(Yutzey et al., 1989), and that of the MEF2 binding site present on it
still remained to be determined (Supplementary Fig. S2). To address
these questions, the core enhancer was used to drive expression of
the Lac Z reporter gene in C2C12 myoblasts alone and in
combination with the promoterless FURE element (Fig. 5). As
expected, the conserved region was able to synergise with the FURE
region. Interestingly, even though the core FIRE drives a much
higher activity as compared with that driven by the full intron
when assayed alone, the synergism among FURE and core FIRE is
clearly shown. Compare lanes in Fig. 5B.
Secondary enhancers from skeletal TnI genes do not harbour any
MEF2 binding site but each one of the primary enhancers holds an
entirely conserved MEF2 site (see Supplementary Figs. S1 and S2). To
test the real contribution of the MEF2 binding sites to quantitative
transcriptional regulation of TnI genes, we examined the transcription
levels driven by a FIRE element in which the MEF2 binding site has
been deleted (FIRE-ΔMEF). The absence of this site in the FIRE primary
enhancer totally abolished the synergism between FURE and FIRE
elements (Fig. 5). Even more, the FIRE-ΔMEF element was still
transcriptionally active when assayed alone. Taken together, these
results clearly demonstrate not only that the interaction is dependent
on the core FIRE, but that MEF2 transcription factor is a key player in
the cooperative interaction between both primary and secondary
enhancers.
Fibre-type speciﬁcity is conferred by the co-operation of primary and
secondary enhancers
The relevance of the synergism effect and ﬁbre-type speciﬁcity in
mammalian skeletal muscles still remained to be tested in vivo. To
address this question, we studied the relative expression and the
ﬁbre-type speciﬁcity of the different sTnI and fTnI gene constructs in
vivo by electroporating them into adult rat muscles (SURE–SIRE,
FURE–FIRE and each element separately: see Materials and methods).
Due to their small size, mouse muscles are very difﬁcult to
electroporate efﬁciently and therefore, we decided to use the rat as
a closely related model animal.To study the expression driven by the different elements in speciﬁc
muscle ﬁbre-types, we examined LacZ levels in transfected ﬁbres of
the Soleus (a slow-twitch oxidative muscle, mainly composed by type
1 slow ﬁbres) and of the EDL muscle (a fast-twitch glycolytic muscle,
mainly composed of 2A, 2B and 2X fast ﬁbres). In order to readily
identify the electroporated ﬁbres, a GFP expression plasmid was co-
transfected with the constructs. Electroporated muscles were exam-
ined 7 days after transfection and serial cross-sections of the Soleus
and EDL muscles were stained with X-Gal to identify the ﬁbres
expressing the reporter gene. In addition, they were immunostained
with speciﬁc antibodies against GFP to detect transfected ﬁbres, or
with speciﬁc antibodies against slow type 1 or fast types 2A or 2BMHC
isoforms to identify the different ﬁbre types (Schiafﬁno and Reggiani,
Fig. 7. Both SURE and SIRE, and FURE and FIRE are required for speciﬁcity in rat EDL
muscles in vivo. Adult rat EDL muscles were co-transfected with constructs harbouring
either SURE–SIRE or FURE–FIRE, and a GFP expression plasmid to normalise for
transfection efﬁciency. Serial transverse cryosections of transfected muscles were
analysed for LacZ and GFP expression, and processed for immunohistochemistry with
monoclonal antibodies speciﬁc to the slow, 2A and 2B MHC isoforms (Schiafﬁno et al.,
1989). FURE–FIRE transfected type 2 (fast) ﬁbres were intensely stained for LacZ while
no slow-type ﬁbres were stained. Moreover, all three types of fast ﬁbres were stained
with the same intensity. In the converse experiments, SURE–SIRE transfected type 2
ﬁbres were not LacZ stained. Fibres that were not positive for any of the MHC markers
were assumed to be 2X fast ﬁbres (orange circles). The 2A and 2B ﬁbres are marked
with yellow and red circles, respectively, and the same myoﬁbres are identiﬁed in the
different pictures. Scale bar, 50 μm.
Table 1
Co-operation of upstream and intronic enhancer elements confers ﬁbre-type speciﬁcity.
Graphic representation of the number of stained ﬁbres when either Soleus (left panel)
or EDL (right panel) rat muscles were transfected with SURE–SIRE (red) or FURE–FIRE
(blue).
24 L. Guerrero et al. / Developmental Biology 337 (2010) 16–281996). Fibres that did not display any of these three makers were
assumed to be fast 2X ﬁbres (Hallauer and Hastings, 2002).
Transfection of constructs harbouring SURE–SIRE resulted in strong
LacZ staining of type 1 ﬁbres, the main ﬁbre population present in the
Soleus muscle (Fig. 6, left panel). In fact, all ﬁbres in the Soleus muscle
of the animals analysed expressed the slow isoform of MHC, whereas
fast MHC isoforms were not identiﬁed in any ﬁbre expressing LacZ
(Table 1). The slow-type speciﬁcity of this construct was conﬁrmed by
the lack of LacZ staining when it was transfected into the EDL muscle
(Fig. 7, right panel, and Table 1). Interestingly, when either SURE or
SIRE alone drove transgene expression, the levels of LacZ expression
were much lower and could only be detected by histochemistry in the
Soleus muscle transfected with SURE. Indeed, LacZ-expressing ﬁbres
were only evident after longer incubation times (24 h, versus 2 h in the
case of transfection with SURE–SIRE, data not shown).
In agreement with these observations, a small amount of β-
galactosidase proteinwas detected inWestern blots when SURE drove
LacZ transcription, but only in the Soleus muscle (Fig. 8). By contrast,
the presence of both SURE (primary enhancer) and SIRE (secondary
enhancer) together produced a more than 10-fold increase in the
amount of β-galactosidase protein compared to that generated by
SURE alone. Our results reveal a strong synergism between both
enhancers in adult skeletal muscle.
Similarly, when FURE–FIRE drove reporter gene transcription, a
very different pattern of LacZ expression was observed in rat EDL
and Soleus muscles. In accordance with the higher fast ﬁbre
content, much higher LacZ expression levels were detected in the
EDL muscle, while as expected LacZ expression was signiﬁcantly
lower in Soleus (Fig. 8). Indeed, the X-Gal stained ﬁbres corre-
sponded to the fast-twitch ﬁbres containing 2A, 2B and/or 2X MHC
(Figs. 6 and 7 and Table 1), and like endogenous TnI, all three
fast ﬁbre types expressed similar levels of LacZ (Fig. 7). The LacZ
expression driven by isolated FURE (secondary enhancer) and FIRE
(primary enhancer) was signiﬁcantly lower than that of the FURE–
FIRE construct in either the EDL or Soleus muscles (data not shown),
conﬁrming the strong synergy between both enhancers in vivo andin agreement with the results obtained for sTnI. In the case of FURE–
FIRE and FIRE, minimal levels of LacZ expression were detected in a
few slow ﬁbres of Soleus muscle after very long incubation times
(24 h, Table 1 and data not shown). A possible transition between
slow and fast ﬁbres, or the presence of mixed ﬁbres, may explain this
observation.
Together, our results reveal that the expression pattern driven by
SURE–SIRE or FURE–FIRE is speciﬁc to slow and fast ﬁbres,
respectively. In other words, the concerted action of both primary
and secondary enhancers is needed to attain high levels of β-
galactosidase expression and to confer complete ﬁbre-type speciﬁcity.
In this sense, it is particularly relevant that the three types of fast ﬁbre
(A, B and X) only express similar levels of LacZ when its expression is
driven by FURE–FIRE (see coloured circles in Fig. 7). Our results
indicate that like Drosophilamuscle genes, the upstream and intronic
Fig. 8. SURE and SIRE, and FURE and FIRE act co-operatively in rat skeletal muscles. Determination of β-galactosidase levels in Western blots of extracts from transfected Soleus and
EDL muscles. Rat muscles were transfected with FURE, FIRE, FURE–FIRE, SURE, SIRE and SURE–SIRE constructs. To normalise for the total protein loading, Troponin I was determined
in each sample.
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levels required to maintain complete ﬁbre-type speciﬁcity, thereby
representing a conserved mechanism.
Cardiac TnI expression is ﬁne-tuned by the co-operation of primary and
secondary enhancer elements
To extend our analysis to the whole TnI family, we studied the
cardiac TnI gene that is exclusively expressed in heart muscle. The
purpose of this study was to determine whether a similar mechanism
to that of skeletal TnI genes operates in the transcriptional regulation
of this cardiac isoform. Using transgenic mice, it has been shown that
cTnI expression in the heart is controlled by a 356 bp (−230/+126)
element, the primary enhancer, located in the upstream region close
to the promoter (Di Lisi et al., 1998). This element is responsible for
strong activation of the cTnI/LacZ transgene, both at early develop-
mental stages and in the adult animal. Hence, we looked for conserved
potential regulatory regions in the ﬁrst introns of cTnI and this in
silico analysis identiﬁed three highly conserved sequences encom-
passing introns 1 to 4, and the proximal end of intron 5 (positions
+127 to +1363, Fig. 9). This newly identiﬁed potential regulatory
region or secondary enhancer was termed CIRE, in accordance with
the nomenclature used herein, whereas the primary enhancer will be
referred to as CURE.
To test whether the conserved intronic region identiﬁed plays a
role in quantitative transcriptional regulation, we performed classical
transcription analysis experiments on each element alone. Moreover,
we assessed the putative interaction between the previously
described CURE and our CIRE element by analysing the transcriptional
activity of the CURE–CIRE combination. Transient transfection assays
of LacZ reporter gene expression in the H9C2 cardiomyocyte cell line
were performed with these three constructs, resulting in very low
levels of LacZ expression in all cases. Indeed, the levels of expression
observed were no higher than those observed with the empty vector
(data not shown). Since the primary enhancer CURE has previously
been shown to drive very high levels of LacZ in transgenic animals (DiLisi et al., 1998), we decided to perform the same analysis using
primary rat cardiomyocytes.
As expected, when single upstream or downstream fragments of
the cTnI gene were transfected into primary cardiomyocytes, only
CURE was able to drive high levels of LacZ expression (Fig. 9). Very
few CIRE transfected cells displayed X-Gal staining and β-galactosi-
dase expression was very low in Western blots (Fig. 9). Surprisingly,
CURE–CIRE also drove lower LacZ expression than CURE alone (Fig. 9).
Thus, the downstream region appears to interact with CURE to restrict
reporter gene expression. Hence, like sTnI and fTnI, the secondary
enhancer contains elements that co-operatewith CURE to regulate the
levels of transcription.
Discussion
In multi-cellular organisms, complex regulatory mechanisms are
required to ensure tight control of tissue-speciﬁc gene expression in
diverse environments. These mechanisms can be categorised as
transcriptional, post-transcriptional and post-translational regulation,
although transcription is probably the most important regulatory
checkpoint in the overall expression of a gene. Here, we have
identiﬁed new conserved enhancer elements in the mouse sTnI, fTnI
and cTnI genes, SIRE, FURE and CIRE, respectively, and we show that
these elements function as secondary enhancers. In collaborationwith
the previously described primary enhancers, SURE, FIRE and CURE
(Banerjee-Basu and Buonanno, 1993; Calvo et al., 2001; Di Lisi et al.,
1998; Hallauer et al., 1993; Hallauer and Hastings, 2002; Rana et al.,
2005), these secondary enhancers control the global regulation of
each one of these genes. In conjunction with our earlier data (Garcia-
Zaragoza et al., 2008; Marco-Ferreres et al., 2005; Mas et al., 2004),
these results suggest that this is a regulatory mechanism evolutionary
conserved from ﬂies to mammals.
In contrast to Drosophila, each of the paired enhancers controlling
muscle TnI genes plays a different function. One of the two enhancers,
the primary enhancer, harbours the activities needed for ﬁbre-type
determination and for transcriptional activation. The secondary
Fig. 9. Co-operation between CURE and CIRE regulates the expression of cTnI. (A) Evolutionary conserved regions in the cTnI gene (ECR browser output), gene organisation and
representation of the analysed fragments. The same colour code as Fig. 1 is displayed. (B) Detection of LacZ expression by X-Gal staining of primary cardiomyocytes transfected
with CURE, CIRE and CURE–CIRE constructs (DM, differentiation medium). Cells were incubated with X-Gal for at least 4 h. (C) Determination of β-galactosidase levels in Western
blots of cell extracts from transfected cardiomyocytes differentiated for 3 days. EV, empty vector. The levels of Luciferase and Troponin I used to normalise for transfection
efﬁciency and total protein loading are shown. Graphic representation of the Western blot data from the ImageJ program. (D) Analysis of β-galactosidase activity in transfected
cardiomyocytes differentiated for 3 days. The β-galactosidase activity was normalised to the luciferase activity and to the protein concentration (see Materials and methods).
Results are the means±SE from 4 different experiments containing 3 replicates of each construct.
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essential role in improving the quality of transcriptional regulation
for ﬁbre-type speciﬁc determination, and in achieving the correct
expression levels required for muscle function. In fact, when theprimary and secondary fTnI and sTnI enhancers are present, reporter
expression is almost 3 times higher than that driven by the primary
enhancer alone when assayed in C2C12, and at least 10 times higher
when assayed in vivo. Moreover, the secondary enhancer of the cTnI
27L. Guerrero et al. / Developmental Biology 337 (2010) 16–28genemodulates the very high expression directed by the primary one.
Thus, as in Drosophila, the overall molecular mechanism underlying
the correct spatio-temporal muscle gene expression at appropriated
levels implies synergistic interactions between the two separate
enhancers in each gene.
As described previously, the three individual primary enhancers,
SURE, FIRE and CURE, function in transgenic slow and fast skeletal
and heart muscles (Banerjee-Basu and Buonanno, 1993; Calvo et al.,
2001; Di Lisi et al., 1998; Hallauer et al., 1993; Hallauer and Hastings,
2002; Rana et al., 2005). These results are consistent with the idea
that each of the three enhancers displays inherent activity and the
basic information to activate ﬁbre-speciﬁc expression. However,
alone they are not fully capable of reproducing the in vivo expression
patterns. In transgenic animals, the FIRE primary enhancer was
previously shown to drive speciﬁc expression exclusively in fast
ﬁbres, although this expression varied among the different types of
ﬁbre and it was higher in 2B and signiﬁcantly lower in 2A (Hallauer
and Hastings, 2002). Using similar approaches, we demonstrate clear
differences in ﬁbre-type speciﬁcity between the construct harbour-
ing FURE–FIRE and that which exclusively harbours FIRE. In this
sense, it is especially relevant that all three types of fast ﬁbres, A, B
and X, only express similar levels of LacZ when its expression is
driven by both primary and secondary enhancers together. Thus, the
presence of both enhancers, FURE and FIRE, is required to reca-
pitulate the endogenous expression observed for the fTnI gene in
Soleus and EDL muscles.
The presence of small amounts of the reporter in FURE–FIRE
transfected rat Soleus and SURE–SIRE transfected rat EDL correlates
well with the ﬁbre composition of both muscles and therefore, it most
probably represents the expression driven in the few fast/slow ﬁbres
present in Soleus or EDL muscles, respectively. The LacZ expression
observed in transverse sections of muscles and differentiated
myotubes electroporated with either the SURE or FIRE constructs is
very low, reﬂecting the incapacity of these fragments to drive the high
levels of expression required for proper sarcomere formation and
function. The relatively low levels of reporter protein detected in
Western blots of SURE in Soleus and FIRE in EDL muscles further
conﬁrm these results. The differences in expression levels are very
signiﬁcant when compared to those driven by the combination of the
URE and IRE enhancers.
In support of our hypothesis, studies aimed at understanding the
regulatory mechanism controlling muscle creatine kinase expression
identiﬁed a highly conserved regulatory region of 900 bp within the
ﬁrst intron of the MCK gene (MR-1). MR-1 exhibits positive
transcriptional activity and it depends on the presence of the proximal
promoter of the MCK gene. The activity of upstream and downstream
regulatory regions was analysed in transgenic mice resulting in
different transcriptional effects depending on the ﬁbre-type (Johnson
et al., 1989). Moreover, using bioinformatic methods, we predict that
the mammalian TnT and TnC genes will have a similar organisation of
potential regulatory enhancers (Supplementary Fig. S3).
Muscle enhancers are short-range enhancers, which means that
they inﬂuence and control transcription of genes in their local
surroundings. It is interesting to note that the primary and secondary
enhancer positions in each mouse TnI gene are not conserved. While
in sTnI and cTnI genes the secondary enhancer is located in an
intronic region, in the fTnI gene it lies at the 5′ ﬂanking sequence.
From an evolutionary point of view, this enhancer distribution
correlates well with previous studies carried out in the TnI gene
family that show sTnI and cTnI to be more closely related to one
another than to fTnI (Cleto et al., 2003; OOta and Saitou, 1999;
Warkman and Atkinson, 2002). On the other hand, comparisons
between our data frommouse TnI, TnT and TnC genes and those from
the Drosophila muscle genes studied previously indicate certain
variability in the location of the intragenic regulatory element of the
pair. Although in most cases this region is located within intron 1, itcan also be found in introns 2 or 3 as is the case of TnT, cTnI or
Drosophila paramyosin genes (Marco-Ferreres et al., 2005; Marin et
al., 2004; Mas et al., 2004).
A key transcription factor involved in regulating the transcription
of speciﬁc genes during skeletal muscle formation and differentiation
is MEF2. An active and important MEF2 binding site has been found in
primary enhancers of mouse skeletal TnI genes that is largely
conserved during evolution (Supplementary Figs. S1 and S2), as
well as in Drosophila muscle enhancers (Arbeitman et al., 2002;
Arredondo et al., 2001; Cripps et al., 2004; Elgar et al., 2008; Kelly et
al., 2002; Lin et al., 1996; Marin et al., 2004; Ranganayakulu et al.,
1995). However, the secondary enhancers from mammals analysed
here do not have conserved MEF2 sites, despite their largely
conserved fragments. In these genes, MEF2 plays an essential role in
mediating the interaction between active primary and secondary
enhancers, which is required for accurate muscle transcription in
mammals. By contrast, in Drosophila both enhancers contain MEF2
binding sites to activate transcription (Arredondo et al., 2001; Garcia-
Zaragoza et al., 2008; Marin et al., 2004; Mas et al., 2004).
Interestingly, recent work in Drosophila has shown that changes in
regulatory elements are an important mechanism to generate animal
diversity during evolution (Jeong et al., 2008). Moreover, a genome
wide study of Dorsal target genes has revealed that a large proportion
of them possess primary and secondary enhancers (Hong et al., 2008),
and that both enhancers contain Dorsal binding sites. Phylogenetic
comparisons have suggested that secondary enhancers in Dorsal
target genes are evolving more rapidly than the primary ones (Hong
et al., 2008). Indeed, secondary muscle enhancers in mammals lack
conservedMEF2 sites.We hypothesised that an ancestral TnI gene had
MEF2 sites in both primary and secondary enhancers as it has in
Drosophila. Posterior duplication of that ancestral gene would have
given rise to the ﬁbre-speciﬁc forms, which kept MEF2 sites in both
enhancers. Throughout evolution, secondarymuscle enhancers would
have lost MEF2 sites, gaining novel binding sites along with new
regulatory functions as the ﬁne-tuning of tissue-speciﬁc transcription
to ensure precise and reproducible patterns of gene expression. Thus
in fTnI, the upstream enhancer evolved as a secondary one loosing the
MEF2 site while this site was maintained in sTnI upstream enhancer.
The term “shadow enhancer” was proposed for “remote secondary
enhancers mapping far from the target gene and mediating activities
overlapping to the primary enhancer.” Shadow enhancers have been
shown to be active and largely redundant when compared to the
primary enhancer, yet they are thought to provide stability in gene
expression throughout the evolution (Hong et al., 2008). By contrast,
secondary enhancers identiﬁed in TnI genes are not active and their
role is to modulate the activity of the primary enhancer. Taking this
into account, we hypothesise that secondary enhancers from TnI
genesmight have evolved from shadow enhancers equivalent to those
identiﬁed in Drosophila. In fTnI, the FURE element might have arisen
from a shadow enhancer while for sTnI and cTnI, the twomore closely
related TnI genes (Cleto et al., 2003; OOta and Saitou, 1999;Warkman
and Atkinson, 2002), the intronic element would have evolved from a
shadow enhacer. Therefore, we propose extending the concept of the
term “shadow enhancer” to those secondary enhancers that ﬁne-tune
the effects of primary enhancers, enabling them to perform new
regulatory functions.
In summary, our results reveal the existence of an evolutionary
conserved mechanism to control precise quantitative expression and
ﬁbre speciﬁcity in each muscle, and maybe in different physiological
situations. Thus, we show the existence of a secondary enhancer in
all three TnI genes, and that the concerted action of primary and
secondary enhancers is required for the correct tissue-speciﬁc ex-
pression of these genes. Hence, we propose a conserved mechanism
of transcriptional regulation in which the synergistic action of two or
maybe more enhancer elements is responsible for both correct
spatio-temporal and quantitative gene expression. This mechanism
28 L. Guerrero et al. / Developmental Biology 337 (2010) 16–28may not be exclusive to muscle tissues but it may also represent a
general mechanism to ﬁne-tune transcriptional regulation in any
other tissue.
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